Banner - Collaborative Care Symposium

News
Media
Conferences
Blog
Publications
Partners
Resources
Subscribe
CE

Paul Smith

Articles by Paul Smith

FDA approves low-dose pilocarpine hydrochloride 0.4% as a treatment for presbyopia

ByLynda Charters,Emily Kaiser Maharjan, Assistant Managing Editor,Elad Kedar,Paul Smith

October 18th 2023

Qlosi (Orasis Pharmaceuticals) approved to treat presbyopia.

SECO 2023: Orasis Pharmaceuticals presents pipeline update at OIS

ByPaul Smith,Emily Kaiser Maharjan, Assistant Managing Editor,Kassi Filkins, Editor

March 3rd 2023

Paul Smith shares an update on Orasis Pharmaceutical's CSF-1 drug and what to expect this year.

Latest Updated Articles

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

Ortho-k: More than meets the eye to control myopia progression

ONL Therapeutics reports positive phase 1b data for xelafaslatide in GA

Crafting your own eyewear brand: Streamlining the private label process

Drs Kaleb Abbott, Andrew Pucker suggest changing "artificial tear" terminology

Crafting your own eyewear brand: An introduction to Logoproject Eyewear

© 2025 MJH Life Sciences^®

All rights reserved.